2 Xideas Ag Abiomed Inc Transaction History

2 Xideas Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $928,736 - $1.15 Million	-3,830 Reduced 9.46%	36,640 $9 Million
Q2 2022 Aug 15, 2022	SELL	$224.73 - $338.64 $765,655 - $1.15 Million	-3,407 Reduced 7.76%	40,470 $10 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $125,317 - $165,563	-452 Reduced 1.02%	43,877 $14.5 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $2.64 Million - $3.26 Million	8,778 Added 24.69%	44,329 $15.9 Million
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $1.92 Million - $2.33 Million	6,181 Added 21.05%	35,551 $11.6 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $582,690 - $778,895	2,218 Added 8.17%	29,370 $9.17 Million
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $1.36 Million - $1.69 Million	4,766 Added 21.29%	27,152 $8.65 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $5.64 Million - $7.26 Million	22,386 New	22,386 $7.26 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of 2 Xideas Ag, based on Form 13F filings with the SEC.

Stay updated on 2 Xideas Ag with notifications on news.